Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID DTD0418 Transporter Info
Gene Name SLC5A1
Transporter Name Sodium/glucose cotransporter 1
Gene ID
6523
UniProt ID
P13866
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Approved Drug

  Dapagliflozin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dapagliflozin inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 [5]

Affected Drug/Substrate

 Methyl-alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)7-SGLT1

  Angiotensin II

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Angiotensin II inhibits the transportation of Glucose by SLC5A1 [8]

Affected Drug/Substrate

 Glucose Modulation Type Inhibition

  Hydroquinone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Hydroquinone increases the expression of SLC5A1 [9]

  Cannabidiol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cannabidiol increases the expression of SLC5A1 [10]

  Sunitinib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sunitinib inhibits the expression of SLC5A1 [11]

  Doxorubicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Doxorubicin inhibits the expression of SLC5A1 [12]

Drug in Phase 3 Trial

  Triclosan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Triclosan inhibits the expression of SLC5A1 [16]

  LX-4211

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 LX-4211 modulates the activity of SLC5A1 [24]

Drug in Phase 2 Trial

  Ethanol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ethanol inhibits the expression of SLC5A1 [18]

  LIK-066

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 LIK-066 inhibits the activity of SLC5A1 [25]

Drug in Phase 1 Trial

  Sodium arsenite

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sodium arsenite inhibits the expression of SLC5A1 [22]

  GSK1614235

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 GSK1614235 blocks the activity of SLC5A1 [23]

  GSK1614235 + GSK2330672

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 GSK1614235 + GSK2330672 modulates the activity of SLC5A1 [25]

Investigative Drug

  Phlorizin

            4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Phlorizin inhibits the transportation of 2-Deoxyglucose by SLC5A1 [1]

Affected Drug/Substrate

 2-Deoxyglucose Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-SGLT1

  DT Modulation 2

 Phlorizin inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 [2]

Affected Drug/Substrate

 Methyl-alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-SGLT1

  DT Modulation 3

 Phlorizin inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 [3]

Affected Drug/Substrate

 Methyl-alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1

  DT Modulation 4

 Phlorizin inhibits the activity of SLC5A1 [4]

  Phloretin

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Phloretin inhibits the transportation of 2-Deoxyglucose by SLC5A1 [1]

Affected Drug/Substrate

 2-Deoxyglucose Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-SGLT1

  DT Modulation 2

 Phloretin inhibits the activity of SLC5A1 [4]

  Alstiphyllanine D

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Alstiphyllanine D inhibits the transportation of Alpha-D-glucopyranoside by SLC5A1 [6]

Affected Drug/Substrate

 Alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1

  Alstiphyllanine E

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Alstiphyllanine E inhibits the transportation of Alpha-D-glucopyranoside by SLC5A1 [6]

Affected Drug/Substrate

 Alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1

  Alstiphyllanine F

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Alstiphyllanine F inhibits the transportation of Alpha-D-glucopyranoside by SLC5A1 [6]

Affected Drug/Substrate

 Alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1

  Formononetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Formononetin inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 [7]

Affected Drug/Substrate

 Methyl-alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1

  Kuraidin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Kuraidin inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 [7]

Affected Drug/Substrate

 Methyl-alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1

  Kurarinone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Kurarinone inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 [7]

Affected Drug/Substrate

 Methyl-alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1

  Kushenol N

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Kushenol N inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 [7]

Affected Drug/Substrate

 Methyl-alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1

  Maackiain

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Maackiain inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 [7]

Affected Drug/Substrate

 Methyl-alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1

  Sophoraflavanone G

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sophoraflavanone G inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 [7]

Affected Drug/Substrate

 Methyl-alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1

  Acerogenin A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acerogenin A inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 [3]

Affected Drug/Substrate

 Methyl-alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1

  Acerogenin B

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acerogenin B inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 [3]

Affected Drug/Substrate

 Methyl-alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1

  Acerogenin C

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acerogenin C inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 [3]

Affected Drug/Substrate

 Methyl-alpha-D-glucopyranoside Modulation Type Inhibition

Cell System

 Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1

  Milchsaure

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Milchsaure inhibits the expression of SLC5A1 [17]

Natural Product

  Particulate Matter

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Particulate Matter increases the expression of SLC5A1 [14]

  Methyleugenol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Methyleugenol inhibits the expression of SLC5A1 [19]

  Hyperoside

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Hyperoside increases the expression of SLC5A1 [20]

  Tobacco Smoke Pollution

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tobacco Smoke Pollution increases the expression of SLC5A1 [21]

Environmental toxicant

  Polychlorinated dibenzodioxin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Polychlorinated dibenzodioxin increases the expression of SLC5A1 [13]

Regulation Mechanism

 via enhancement of Aryl hydrocarbon receptor (AHR) Transcription Factor Info

Cell System

 C57BL/6J mice

Mycotoxins

  Aflatoxin B1

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aflatoxin B1 inhibits the expression of SLC5A1 [19]

Acute Toxic Substance

  Ochratoxin A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ochratoxin A inhibits the expression of SLC5A1 [15]

Carcinogen

  Benzo(a)pyrene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzo(a)pyrene inhibits the expression of SLC5A1 [19]

Health and Environmental Toxicant

  Caffeic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Caffeic acid increases the expression of SLC5A1 [20]
References
1 Targeting Type 2 Diabetes with C-Glucosyl Dihydrochalcones as Selective Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Synthesis and Biological Evaluation. J Med Chem. 2017 Jan 26;60(2):568-579.
2 Tripeptides of RS1 (RSC1A1) inhibit a monosaccharide-dependent exocytotic pathway of Na+-D-glucose cotransporter SGLT1 with high affinity. J Biol Chem. 2007 Sep 28;282(39):28501-13.
3 Cyclic diarylheptanoids as Na+-glucose cotransporter (SGLT) inhibitors from Acer nikoense. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1070-4.
4 Probing the conformation of the sugar transport inhibitor phlorizin by 2D-NMR, molecular dynamics studies, and pharmacophore analysis. J Med Chem. 2000 May 4;43(9):1692-8.
5 O-Spiro C-aryl glucosides as novel sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5632-5.
6 Alstiphyllanines E-H, picraline and ajmaline-type alkaloids from Alstonia macrophylla inhibiting sodium glucose cotransporter. Bioorg Med Chem. 2010 Mar 15;18(6):2152-2158.
7 Na+-glucose cotransporter (SGLT) inhibitory flavonoids from the roots of Sophora flavescens. Bioorg Med Chem. 2007 May 15;15(10):3445-9.
8 Angiotensin II exerts dual actions on sodium-glucose transporter 1-mediated transport in the human jejunal mucosa. Scand J Gastroenterol. 2015;50(9):1068-75.
9 Keratinocyte-derived IL-36 Gamma plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
10 Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321.
11 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761.
12 RNA sequence analysis of inducible pluripotent stem cell-derived cardiomyocytes reveals altered expression of DNA damage and cell cycle genes in response to doxorubicin. Toxicol Appl Pharmacol. 2018 Oct 1;356:44-53.
13 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced change in intestinal function and pathology: evidence for the involvement of arylhydrocarbon receptor-mediated alteration of glucose transportation. Toxicol Appl Pharmacol. 2005 May 15;205(1):89-97.; 2005 May 15;205(1):89-97.
14 Transcriptome analysis of airborne PM2.5-induced detrimental effects on human keratinocytes. Toxicol Lett. 2017 May 5;273:26-35.
15 Synergistic action of the nephrotoxic mycotoxins ochratoxin A and citrinin at nanomolar concentrations in human proximal tubule-derived cells. Toxicol Lett. 2018 Jul;291:149-157.
16 Transcriptome and DNA Methylome Dynamics during Triclosan-Induced Cardiomyocyte Differentiation Toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
17 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
18 Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Toxicol Sci. 2019 May 1;169(1):280-292.
19 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297.
20 Glucose absorption regulation and mechanism of the compounds in Lilium lancifolium Thunb on Caco-2 cells. Food Chem Toxicol. 2021 Mar;149:112010.
21 Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. Arch Toxicol. 2021 May;95(5):1739-1761.
22 Dynamic alteration in miRNA and mRNA expression profiles at different stages of chronic arsenic exposure-induced carcinogenesis in a human cell culture model of skin cancer. Arch Toxicol. 2021 Jul;95(7):2351-2365.
23 Clinical pipeline report, company report or official report of GlaxoSmithKline (2009).
24 LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial. Clin Pharmacol Ther. 2012 Aug;92(2):158-69.
25 Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 915).

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.